Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab in Active Rheumatoid Arthritis
NCT00299130Phase 3Completed
- Sponsor
- Genentech
- Start
- Oct 2005
- Primary completion
- Jun 2008
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of rituximab in rheumatoid arthritis (RA), sponsored by Genentech. Started Oct 2005; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00299130.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299130.